نتایج جستجو برای: xpert mtbrif assay

تعداد نتایج: 222590  

2016
Yong Suk Jo Ju-Hee Park Jung Kyu Lee Eun Young Heo Hee Soon Chung Deog Kyeom Kim

The prevalence and clinical implications of discordance between Xpert MTB/RIF assays and the AdvanSure TB/NTM real-time polymerase chain reaction (PCR) for bronchial washing specimens have not been studied in pulmonary TB (PTB) patients. The discordant proportion and its clinical impact were evaluated in 320 patients from the bronchoscopy registry whose bronchial washing specimens were tested s...

Journal: :Journal of clinical microbiology 2014
Syed Beenish Rufai Parveen Kumar Amit Singh Suneel Prajapati Veena Balooni Sarman Singh

The MTBDRplus line probe assay (LPA) and Xpert MTB/RIF have been endorsed by the World Health Organization for the rapid diagnosis of drug-resistant tuberculosis. However, there is no clarity regarding the superiority of one over the other. In a double-blinded prospective study, we evaluated the efficacy of the Xpert MTB/RIF on samples that were first tested by LPA under the revised national tu...

2017
Sunil Khaparde Neeraj Raizada Sreenivas Achuthan Nair Claudia Denkinger Kuldeep Singh Sachdeva Chinnambedu Nainarappan Paramasivan Virender Singh Salhotra Anna Vassall Anja Van't Hoog

BACKGROUND India is considering the scale-up of the Xpert MTB/RIF assay for detection of tuberculosis (TB) and rifampicin resistance. We conducted an economic analysis to estimate the costs of different strategies of Xpert implementation in India. METHODS Using a decision analytical model, we compared four diagnostic strategies for TB patients: (i) sputum smear microscopy (SSM) only; (ii) Xpe...

Journal: :Journal of clinical microbiology 2014
Vanessa Deggim Akos Somoskovi Guido Bloemberg

In our recently published paper “Integrating the Xpert MTB/RIF Assay into a Diagnostic Workflow for Rapid Detection of Mycobacterium tuberculosis in a Low-Prevalence Area” (1), we express our concerns on the accurate reporting of RIF results by the Xpert MTB/RIF assay and its limited use for nonrespiratory samples. With interest, we read the comments of Blaich and Frei (2) on our paper, in whic...

Journal: :Journal of clinical microbiology 2012
P Pancholi C Kelly M Raczkowski J M Balada-Llasat

Clostridium difficile is the most important cause of nosocomial diarrhea. Several laboratory techniques are available to detect C. difficile toxins or the genes that encode them in fecal samples. We evaluated the Xpert C. difficile and Xpert C. difficile/Epi (Cepheid, CA) that detect the toxin B gene (tcdB) and tcdB, cdt, and a deletion in tcdC associated with the 027/NAP1/BI strain, respective...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Christopher K Lippincott Melissa B Miller Elena B Popowitch Colleen F Hanrahan Annelies Van Rie

BACKGROUND In the United States, individuals with presumptive pulmonary tuberculosis are placed in airborne infection isolation (AII) and assessed by smear microscopy on 3 respiratory specimens collected 8-24 hours apart. Xpert MTB/RIF assay (Xpert) on 1, 2, or 3 specimens may be more efficient for determining AII discontinuation. METHODS This single-center, observational cohort study of inpa...

Journal: :The lancet. Gastroenterology & hepatology 2017
Jason Grebely Francois M J Lamoury Behzad Hajarizadeh Yasmin Mowat Alison D Marshall Sahar Bajis Philippa Marks Janaki Amin Julie Smith Michael Edwards Carla Gorton Nadine Ezard David Persing Marika Kleman Philip Cunningham Beth Catlett Gregory J Dore Tanya L Applegate

BACKGROUND Point-of-care hepatitis C virus (HCV) RNA testing offers an advantage over antibody testing (which only indicates previous exposure), enabling diagnosis of active infection in a single visit. In this study, we evaluated the performance of the Xpert HCV Viral Load assay with venepuncture and finger-stick capillary whole-blood samples. METHODS Plasma and finger-stick capillary whole-...

Journal: :The European respiratory journal 2015
John Z Metcalfe Salome Makumbirofa Beauty Makamure Reggie Mutetwa Renée A Peñaloza Charles Sandy Wilbert Bara Stanley Mungofa Philip C Hopewell Peter Mason

The Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) is strongly recommended by the World Health Organization as an initial diagnostic test for treatment-experienced patients of any retreatment category [1–3]. Yet, retreatment tuberculosis (TB) suspects have been infrequently included in studies of Xpert [4], probably because current-generation PCR-based tests are unable to determine Mycobacte...

2015
Benjamin A. Pinsky Malaya K. Sahoo Johanna Sandlund Marika Kleman Medha Kulkarni Per Grufman Malin Nygren Robert Kwiatkowski Ellen Jo Baron Fred Tenover Blake Denison Russell Higuchi Reuel Van Atta Neil Reginald Beer Alda Celena Carrillo Pejman Naraghi-Arani Chad E. Mire Charlene Ranadheera Allen Grolla Nina Lagerqvist David H. Persing

BACKGROUND The recently developed Xpert® Ebola Assay is a novel nucleic acid amplification test for simplified detection of Ebola virus (EBOV) in whole blood and buccal swab samples. The assay targets sequences in two EBOV genes, lowering the risk for new variants to escape detection in the test. The objective of this report is to present analytical characteristics of the Xpert® Ebola Assay on ...

2017
M. Chipinduro K. Mateveke B. Makamure R. A. Ferrand E. Gomo

OBJECTIVE To evaluate the diagnostic performance of Xpert® MTB/RIF on stool samples from children with clinical suspicion of pulmonary tuberculosis (PTB) at primary care clinics. DESIGN A cross-sectional diagnostic evaluation enrolling 5-16 year olds from whom one induced sputum (IS) sample was tested for microbiological TB confirmation. Results of a single stool sample tested using Xpert wer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید